Reaction

Pleural Fibrosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,017 reports · 47 co-occurring drugs

As of the last recalculation, Pleural Fibrosis appears in 1,017 FAERS reports alongside 47 co-occurring drug terms. The strongest observed disproportionality signal is TRAZODONE HYDROCHLORIDE (PRR 127.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Trazodone Hydrochloride89127.5128.3
Loperamide Hydrochloride Oral58123.2123.9
Diphenoxylate Hydrochloride And Atropine Sulfate70112.2112.8
Loperamide Hcl5999.6100.0
Risedronate Sodium12997.197.5
Thiamine Hydrochloride5188.288.6
Mometasone Furoate14784.284.5
Ascorbic Acid6056.056.2
Sulfasalazine15748.448.5
Biotin6646.246.3
Fentanyl16440.440.5
Chlorhexidine Gluconate1738.738.8
Meperidine Hydrochloride1636.136.2
Esomeprazole9534.534.5
Celecoxib17432.432.5
Tocilizumab15231.931.9
Methylprednisolone Acetate1231.031.1
Loperamide Hydrochloride6330.730.7
Acetaminophen, Guaifenesin, And Phenylephrine Hydrochloride18428.528.5
Hydroxychloroquine Sulfate10726.726.8
Hydroxychloroquine8926.626.7
Abatacept15126.026.1
Naproxen Sodium Tablet, Coated1624.624.6
Naproxen Sodium, Coated Tablets1624.624.6
Naproxen Sodium 220Mg1624.524.5
Exemestane2524.524.5
Psyllium Husk1123.023.1
Leflunomide10322.322.3
Oxycodone Hydrochloride18020.420.4
Fulvestrant3119.819.8
Oxycodone And Acetaminophen Tablets1119.119.1
Hyoscyamine Sulfate818.018.0
Ezetimibe And Simvastatin1317.717.7
Erlotinib714.914.9
Zoledronic Acid2513.013.0
Letrozole3712.712.7
Oxycodone And Acetaminophen1311.611.6
Erlotinib Hydrochloride711.511.5
Oxycodone Hydrochloride And Acetaminophen5211.311.3
Lapatinib79.39.3
Tofacitinib779.29.2
Pemetrexed Disodium168.78.7
Pemetrexed98.78.7
Etanercept1988.28.2
Conjugated Estrogens And Medroxyprogesterone Acetate76.16.1
Olaparib65.95.9
Vigabatrin45.65.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.